Extensive-Stage Small-Cell Lung Cancer: Current Landscape and Future Prospects

Small-cell lung cancer (SCLC) is characterized by aggressive disease progression and tendency to metastasize. Although chemotherapy for extensive-stage SCLC (ES-SCLC) has remained unchanged for decades, immune checkpoint inhibitors have become the primary therapy for ES-SCLC. However, the number of...

Descripción completa

Detalles Bibliográficos
Autores principales: Saida, Yu, Watanabe, Satoshi, Kikuchi, Toshiaki
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10404428/
https://www.ncbi.nlm.nih.gov/pubmed/37551311
http://dx.doi.org/10.2147/OTT.S272552

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10404428/
https://www.ncbi.nlm.nih.gov/pubmed/37551311
http://dx.doi.org/10.2147/OTT.S272552

Ejemplares similares